Table 4 Continuous T3 and risk of specific prognostic factors in breast cancer
Tumour group | HR (95% CI) | HR*(95% CI) | HR**(95% CI) |
|---|---|---|---|
All | 1.57 (1.06-2.32) | 1.75 (1.18-2.60) | 1.89 (1.27-2.82) |
Grade I | 0.93 (0.40-2.13) | 1.00 (0.42-2.39) | 1.20 (0.50-2.89) |
Grade II | 2.45 (1.32-4.55) | 2.61 (1.40-4.87) | 2.68 (1.42-5.06) |
Grade III | 1.68 (0.75-3.80) | 1.78 (0.80-4.10) | 1.86 (0.80-4.36) |
Size ≤20 mm | 1.53 (0.90-2.60) | 1.65 (0.96-2.84) | 1.88 (1.09-3.23) |
Size >20 mm | 1.98 (0.96-4.09) | 2.11 (1.01-4.41) | 1.96 (0.90-4.26) |
Node positive | 2.81 (1.39-5.67) | 3.13 (1.57-6.23) | 3.34 (1.70-6.56) |
Node negative | 1.18 (0.68-2.05) | 1.22 (0.68-2.17) | 1.32 (0.73-2.38) |
ER positive | 1.38 (0.83-2.28) | 1.46 (0.87-2.46) | 1.60 (0.95-2.71) |
ER negative | 3.95 (1.97-7.90) | 4.15 (2.08-8.30) | 4.32 (2.16-8.61) |
PGR positive | 1.38 (0.82-2.33) | 1.48 (0.86-2.53) | 1.57 (0.91-2.71) |
PGR negative | 3.38 (1.74-6.56) | 3.53 (1.80-6.89) | 3.89 (2.02-7.50) |